Ohno Publishes Review on Therapies Targeting BACE1
New York – Dr. Masuo Ohno of the CDR, authors a review, titled “Alzheimer’s therapy targeting the beta-secretase enzyme BACE1: Benefits and potential limitations from the perspective of animal model studies,” which appears in the April issue of the Brain Research Bulletin.